Health insurance for genetic tests

Health insurance for genetic tests means that a policy covers, partially covers, or excludes payment for laboratory analysis of DNA to detect disease risks. Most US insurers, including Aetna and UnitedHealthcare, cover medically necessary genetic tests like BRCA1/BRCA2 if ordered by a physician; elective tests such as 23andMe are typically excluded, as confirmed by YourInsurance.info.

Coverage criteria usually require family history or clinical symptoms; for example, Blue Cross Blue Shield (BCBS) restricts payment to patients meeting National Comprehensive Cancer Network guidelines. Out-of-pocket costs for uncovered genetic testing can range from $100 to over $5,000 per test, with Medicare covering only tests deemed medically reasonable and necessary since 2015.

Insurers may require pre-authorization for multigene panels, according to Cigna’s medical policy documents. Denials most commonly cite lack of medical necessity or absence of supporting documentation.

Covered tests include hereditary cancer screening (e.g. Lynch syndrome), pharmacogenomics (e.g.

CYP2C19 for Plavix response), and prenatal diagnostics (e.g. cystic fibrosis panel); noncovered examples include ancestry tests and direct-to-consumer health risk reports. Genetic counseling is often covered but may need separate approval–Aetna limits coverage to certified providers.

Privacy laws like GINA prohibit health insurers from using predictive genetic data in underwriting but do not apply to life or disability insurance. Patients can appeal denials following insurer-specific procedures; in 2022, Kaiser Permanente reported an appeal overturn rate of about 28% for denied genetic test claims.

Telegenetics services have expanded coverage since COVID-19 emergency policies; UnitedHealthcare now reimburses video-based genetic counseling when medically indicated.